Here are 13 observations:
1. Implanet saw a 45 percent jump in spine activity in 2016, compared to 2015.
2. Spine sales reached $4.39 million in 2016.
3. Spurred by a 46 percent increase in spine activity, the company saw growth of 18 percent in 2016.
4. In 2016, spine sales ($4.39 million) surpassed knee sales ($3.98 million) for the first time.
5. Implanet sold 1,450 JAZZ implants in the United States; 3,552 in France; and 1,999 in the rest of the world.
6. As of Dec. 31, 2016, 127 surgeons used the company’s JAZZ technology.
7. Implanet saw a 36 percent jump in pediatric scoliosis surgery segment in 2016, up from 2015.
8. In Q4 2016, the company saw a 36 percent growth in total sales, reaching $2.35 million.
9. Spine sales grew 121 percent in Q4 2016, compared to 2015.
10. The company sold 2,437 JAZZ implants in Q4 2016.
11. In the United States, JAZZ sales grew 163 percent to about $531,000 in Q4 2016.
12. In France, JAZZ sales increased by 55 percent to about $362,000 in Q4 2016.
13. In the high-potential degenerative bone disorder segment, the company saw a 149 percent boost to about $414,000 in Q4 2016.
More articles on devices:
Zimmer Biomet, J&J, Stryker & more: 15 device company key notes
US Patent Office allows Aurora Spine’s patent for polyaxial ZIP ISP: 4 things to know
Whale Imaging earns FDA approval for next-generation G-Arm — 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
